DaveManuel.com · Institutional Ownership · Who Owns It
BIODEXA PHARMACEUTICALS PLC (BDRX)
Institutional ownership reported to the SEC as of Q2 2026, across 15 quarters.
8
Reporting holders
$48.1K
Reported value
0.0%
Calls
0.0%
Puts
+0
Holder change
Calls and puts are the parts of reported value carried in derivative lines rather than shares, and they point in opposite directions: a manager holding calls is positioned for the security, one holding puts against it - or hedging shares they already own, which is why index funds carry so many. Most sites add the two together and report one figure, which averages away the only interesting part.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | $43.1K | 14,809 | 0.00% | new | NEW |
| GAMMA Investing LLC | $3.5K | 1,203 | 0.00% | new | NEW |
| Allied Private Wealth LLC | $1.3K | 489 | 0.00% | new | FIRST |
| SBI Securities Co., Ltd. | $84 | 29 | 0.00% | 2q | -80.8% |
| UBS Group AG | $73 | 25 | 0.00% | new | NEW |
| Hilton Head Capital Partners, LLC | $17 | 6 | 0.00% | new | NEW |
| Caitong International Asset Management Co., Ltd | $15 | 5 | 0.00% | new | NEW |
| RHUMBLINE ADVISERS | $8 | 3 | 0.00% | 4q | -84.2% |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q3 2026 | 2 | $13 | 20 | 0 | 0 | 2 | 0.0% |
| Q2 2026 | 8 | $48.1K | 16,569 | 5 | 0 | 2 | 0.0% |
| Q1 2026 | 8 | $228.1K | 369,101 | 2 | 2 | 3 | 0.0% |
| Q4 2025 | 8 | $692.9K | 305,273 | 3 | 2 | 2 | 0.0% |
| Q3 2025 | 4 | $55.8K | 8,397 | 4 | 0 | 0 | 0.0% |
| Q2 2025 | 4 | $17.0K | 19,666 | 0 | 2 | 2 | 0.0% |
| Q1 2025 | 6 | $28.1K | 21,314 | 2 | 2 | 0 | 0.0% |
| Q4 2024 | 4 | $29.3K | 7,242 | 3 | 0 | 0 | 0.0% |
| Q3 2024 | 6 | $87.3K | 309,668 | 0 | 4 | 1 | 0.0% |
| Q2 2024 | 12 | $135.6K | 151,447 | 7 | 2 | 3 | 0.0% |
| Q1 2024 | 5 | $31.3K | 19,321 | 0 | 3 | 0 | 0.0% |
| Q4 2023 | 7 | $169.2K | 63,695 | 3 | 3 | 0 | 0.0% |
| Q3 2023 | 5 | $58.9K | 12,098 | 5 | 0 | 0 | 0.0% |
| Q2 2023 | 8 | $45.8K | 670,534 | 5 | 1 | 0 | 0.0% |
| Q1 2023 | 7 | $72.0K | 185,836 | 7 | 0 | 0 | 0.0% |